maintain hold rate follow decent result mark solid kidney
care volum stabl commerci mix reiter guidanc kidney
care remain upbeat dmg sale remov overhang full price
track close expect improv trend see
labor bad debt cash flow strong remain kidney busi
carri materi higher visibl updat estim maintain
hold bump target ebitda
get back compet pend sale dmg
optum nr solid trend kidney busi move
back forefront saw natg within long term growth
expect revenue/tx
year line expect payor mix driven declin
cost/tx continu improv yoy tie renegoti
nr contract benefit non-recur
provid off-set on-going labor pressur adjust oper incom
ahead tie cost/tx improv
coupl non-recur benefit health solut share save
insur adjust ep
dmg sale track sale dmg progress track close
continu view deal favor remov sizabl overhang
result also whelm impact flu season
provid sizabl cash inflow allow focu core kidney care
busi compani expect use proce debt repay share
repurchas remaind reserv invest long term growth
detail cap ex go cffo ex-nci
roughli in-lin
repurchas stock bought anoth
compani exit year cash debt net-debt-to-
ebitda interestingli manag announc expect
increas cap ex evenli split growth mainten
expect normal back toward level find bit
puzzl given plan divestitur dmg await detail think
intern invest ramp could card
guidanc kidney guidanc unchang
cffo expect rang expect tax rate
tr target
bump bp updat ep estim
reflect dmg sale guidanc
updat new leadership busi turn focu core
market compani optimist scale financial/clin valu divis also
streamlin improv report structur improv effici gener
save expect annual continu view attractive/
potenti meaning opportun time manag reiter expect oi break
even late
page
revenu
revenu
revenu
revenu
revenu
amort net tax
page
base denver co davita healthcar partner inc lead provid dialysi servic
unit state patient suffer chronic kidney failur end stage renal diseas esrd
compani enter agreement sell davita medic group optum
transact expect close
continu like core dialysi busi acknowledg potenti opportun tie
integr care longer term think dmg segment higher oper variabl increas
risk suggest lower multipl profit stream continu concern relat
premium assist remain upbeat potenti long-term opportun improv
trend dmg remain key
valuat risk
price target base trade adjust ebitda discount
industri peer freseniu medic view appropri given less product geograph
diversif risk price target upsid includ better expect reimburs
oper perform downsid risk includ wors expect reimburs pressur
slow organ trend
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
